Atherosclerosis and vascular disease: effects of peptide mimetics of apolipoproteins

Area of Science:

• Biochemistry
• Cardiovascular Science
• Pharmacology

Background:

• High-density lipoprotein (HDL) and apolipoprotein A-I (apo A-I) levels correlate with reduced vascular disease risk.
• Apo A-I possesses protective functions including reverse cholesterol transport, anti-inflammatory, anti-oxidative, and vascular modulation activities.
• Apo A-I features lipid-associating domains with class A amphipathic helices.

Purpose of the Study:

• To investigate the functional mimicry of apo A-I by synthetic peptides.
• To evaluate the therapeutic potential of peptide mimetics in preventing atherosclerosis and vascular diseases.

Main Methods:

• Design and synthesis of peptide analogs with class A amphipathic helix motifs.
• Assessment of phospholipid association and functional properties of peptide mimetics.
• In vivo evaluation of peptide 4F in animal models for atherosclerosis inhibition, inflammation, oxidation, and vascular function.

Main Results:

• Peptide analogs with class A motifs mimic apo A-I's functional properties, including phospholipid association.
• Peptide 4F demonstrated maximal efficacy in mimicking apo A-I's protective qualities.
• Peptide 4F inhibited atherosclerosis, reduced inflammation and oxidation, and improved vascular function in animal models.
• D-amino acid synthesized peptide 4F exhibited oral bioavailability.

Conclusions:

• Peptide mimetics are powerful tools for studying apolipoprotein function.
• Peptide 4F and similar analogs hold potential as novel therapeutic agents for atherosclerosis and vascular diseases.
• Further research into peptide mimetics may elucidate functions of other apolipoproteins like apo E and apo J.